Edarbi FDA Approval History
FDA Approved: Yes (First approved February 25, 2011)
Brand name: Edarbi
Generic name: azilsartan medoxomil
Dosage form: Tablets
Company: Azurity Pharmaceuticals, Inc.
Treatment for: High Blood Pressure
Edarbi (azilsartan medoxomil) is an angiotensin II receptor blocker (ARB) for the treatment of hypertension.
Development timeline for Edarbi
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
